Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase

David Loch, Andrew Hoey, Christophe Morisseau, Bruce O. Hammock, Lindsay Brown

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Cyclooxygenase and lipoxygenase metabolism of arachidonic acid produces compounds important in cardiovascular control. Further, arachidonic acid can be metabolised by cytochrome p450 to produce epoxyeicosatrienoic acids (EETs). These derivatives are inactivated by soluble epoxide hydrolase (sEH). The potential role of these EETs in hypertension and cardiac remodelling has been determined using the selective sEH inhibitor, N-adamantyl-N'-dodecylurea (ADU), in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Experiments were performed on male Wistar rats following uninephrectomy alone (UNX rats) or uninephrectomy with administration of DOCA (25 mg every fourth day subcutaneously) and 1% NaCl in drinking water (DOCA-salt rats). ADU (10 mg/kg/d subcutaneously) was administered for 2 wk starting 2 wk after surgery. Cardiovascular structure and function were determined using organ wet weights, histological analysis of collagen and inflammation, isolated heart and thoracic aortic ring preparations, and electrophysiological measurements. DOCA-salt hypertensive rats developed hypertension, hypertrophy, perivascular and interstitial fibrosis, endothelial dysfunction, and prolongation of the cardiac action potential duration within 4 wk. Administration of ADU prevented the further increase in systolic blood pressure and left-ventricular wet weight and normalized endothelial function. ADU treatment did not change inflammatory cell infiltration, collagen deposition, or cardiac action potential duration. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities.

Original languageEnglish (US)
Pages (from-to)87-97
Number of pages11
JournalCell Biochemistry and Biophysics
Volume47
Issue number1
StatePublished - Jan 2007

Fingerprint

Epoxide Hydrolases
Desoxycorticosterone
Rats
Acetates
Salts
Hypertension
Collagen
Action Potentials
Arachidonic Acid
Arachidonate Lipoxygenases
Blood Pressure
Organ Size
Prostaglandin-Endoperoxide Synthases
Lipoxygenase
Drinking Water
Cytochrome P-450 Enzyme System
Hypertrophy
Blood pressure
Wistar Rats
Infiltration

Keywords

  • DOCA-salt rats
  • Epoxyeicosatrienoic acids (EETs)
  • Hypertension
  • Remodeling
  • Soluble epoxide hydrolase (sEH)

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry
  • Biophysics

Cite this

Loch, D., Hoey, A., Morisseau, C., Hammock, B. O., & Brown, L. (2007). Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. Cell Biochemistry and Biophysics, 47(1), 87-97.

Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. / Loch, David; Hoey, Andrew; Morisseau, Christophe; Hammock, Bruce O.; Brown, Lindsay.

In: Cell Biochemistry and Biophysics, Vol. 47, No. 1, 01.2007, p. 87-97.

Research output: Contribution to journalArticle

Loch, D, Hoey, A, Morisseau, C, Hammock, BO & Brown, L 2007, 'Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase', Cell Biochemistry and Biophysics, vol. 47, no. 1, pp. 87-97.
Loch, David ; Hoey, Andrew ; Morisseau, Christophe ; Hammock, Bruce O. ; Brown, Lindsay. / Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. In: Cell Biochemistry and Biophysics. 2007 ; Vol. 47, No. 1. pp. 87-97.
@article{e74eadf6986f4dbf98411dcdd0b87d33,
title = "Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase",
abstract = "Cyclooxygenase and lipoxygenase metabolism of arachidonic acid produces compounds important in cardiovascular control. Further, arachidonic acid can be metabolised by cytochrome p450 to produce epoxyeicosatrienoic acids (EETs). These derivatives are inactivated by soluble epoxide hydrolase (sEH). The potential role of these EETs in hypertension and cardiac remodelling has been determined using the selective sEH inhibitor, N-adamantyl-N'-dodecylurea (ADU), in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Experiments were performed on male Wistar rats following uninephrectomy alone (UNX rats) or uninephrectomy with administration of DOCA (25 mg every fourth day subcutaneously) and 1{\%} NaCl in drinking water (DOCA-salt rats). ADU (10 mg/kg/d subcutaneously) was administered for 2 wk starting 2 wk after surgery. Cardiovascular structure and function were determined using organ wet weights, histological analysis of collagen and inflammation, isolated heart and thoracic aortic ring preparations, and electrophysiological measurements. DOCA-salt hypertensive rats developed hypertension, hypertrophy, perivascular and interstitial fibrosis, endothelial dysfunction, and prolongation of the cardiac action potential duration within 4 wk. Administration of ADU prevented the further increase in systolic blood pressure and left-ventricular wet weight and normalized endothelial function. ADU treatment did not change inflammatory cell infiltration, collagen deposition, or cardiac action potential duration. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities.",
keywords = "DOCA-salt rats, Epoxyeicosatrienoic acids (EETs), Hypertension, Remodeling, Soluble epoxide hydrolase (sEH)",
author = "David Loch and Andrew Hoey and Christophe Morisseau and Hammock, {Bruce O.} and Lindsay Brown",
year = "2007",
month = "1",
language = "English (US)",
volume = "47",
pages = "87--97",
journal = "Cell Biochemistry and Biophysics",
issn = "1085-9195",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase

AU - Loch, David

AU - Hoey, Andrew

AU - Morisseau, Christophe

AU - Hammock, Bruce O.

AU - Brown, Lindsay

PY - 2007/1

Y1 - 2007/1

N2 - Cyclooxygenase and lipoxygenase metabolism of arachidonic acid produces compounds important in cardiovascular control. Further, arachidonic acid can be metabolised by cytochrome p450 to produce epoxyeicosatrienoic acids (EETs). These derivatives are inactivated by soluble epoxide hydrolase (sEH). The potential role of these EETs in hypertension and cardiac remodelling has been determined using the selective sEH inhibitor, N-adamantyl-N'-dodecylurea (ADU), in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Experiments were performed on male Wistar rats following uninephrectomy alone (UNX rats) or uninephrectomy with administration of DOCA (25 mg every fourth day subcutaneously) and 1% NaCl in drinking water (DOCA-salt rats). ADU (10 mg/kg/d subcutaneously) was administered for 2 wk starting 2 wk after surgery. Cardiovascular structure and function were determined using organ wet weights, histological analysis of collagen and inflammation, isolated heart and thoracic aortic ring preparations, and electrophysiological measurements. DOCA-salt hypertensive rats developed hypertension, hypertrophy, perivascular and interstitial fibrosis, endothelial dysfunction, and prolongation of the cardiac action potential duration within 4 wk. Administration of ADU prevented the further increase in systolic blood pressure and left-ventricular wet weight and normalized endothelial function. ADU treatment did not change inflammatory cell infiltration, collagen deposition, or cardiac action potential duration. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities.

AB - Cyclooxygenase and lipoxygenase metabolism of arachidonic acid produces compounds important in cardiovascular control. Further, arachidonic acid can be metabolised by cytochrome p450 to produce epoxyeicosatrienoic acids (EETs). These derivatives are inactivated by soluble epoxide hydrolase (sEH). The potential role of these EETs in hypertension and cardiac remodelling has been determined using the selective sEH inhibitor, N-adamantyl-N'-dodecylurea (ADU), in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Experiments were performed on male Wistar rats following uninephrectomy alone (UNX rats) or uninephrectomy with administration of DOCA (25 mg every fourth day subcutaneously) and 1% NaCl in drinking water (DOCA-salt rats). ADU (10 mg/kg/d subcutaneously) was administered for 2 wk starting 2 wk after surgery. Cardiovascular structure and function were determined using organ wet weights, histological analysis of collagen and inflammation, isolated heart and thoracic aortic ring preparations, and electrophysiological measurements. DOCA-salt hypertensive rats developed hypertension, hypertrophy, perivascular and interstitial fibrosis, endothelial dysfunction, and prolongation of the cardiac action potential duration within 4 wk. Administration of ADU prevented the further increase in systolic blood pressure and left-ventricular wet weight and normalized endothelial function. ADU treatment did not change inflammatory cell infiltration, collagen deposition, or cardiac action potential duration. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities.

KW - DOCA-salt rats

KW - Epoxyeicosatrienoic acids (EETs)

KW - Hypertension

KW - Remodeling

KW - Soluble epoxide hydrolase (sEH)

UR - http://www.scopus.com/inward/record.url?scp=34147160073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147160073&partnerID=8YFLogxK

M3 - Article

C2 - 17406062

AN - SCOPUS:34147160073

VL - 47

SP - 87

EP - 97

JO - Cell Biochemistry and Biophysics

JF - Cell Biochemistry and Biophysics

SN - 1085-9195

IS - 1

ER -